Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0 T to assess aggressiveness of bladder cancer

European Journal of Radiology

Volumn 83, Issue 11, 2014, Pages 2013-2018

  Zhou, Guoxing ^a   Chen, Xiao ^a,b   Zhang, Jianhua ^a   Zhu, Jingqi ^a   Zong, Genlin ^a   Wang, Zhongqiu ^b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Apparent diffusion coefficient; Bladder cancer; Dynamic contrast enhancement; Magnetic resonance imaging

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER SURGERY; CANCER AGGRESSIVENESS; CANCER SIZE; CANCER STAGING; CONTRAST ENHANCEMENT; CYSTECTOMY; DIAGNOSTIC ACCURACY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DYNAMIC CONTRAST ENHANCED NUCLEAR MAGNETIC RESONANCE IMAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGICAL PARAMETERS; SENSITIVITY AND SPECIFICITY; BLADDER TUMOR; CANCER GRADING; EVALUATION STUDY; FEASIBILITY STUDY; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROSPECTIVE STUDY; RADIOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; VERY ELDERLY;

CONTRAST MEDIUM;

AGED; AGED, 80 AND OVER; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS;

EID: 84908276172     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2014.08.012     Document Type: Article

References (22)

1. Jacobs BL, Lee CT, Montie JE. Bladder cancer in 2010: how far have we come? CA Cancer J Clin 2010;60(4):244-72.
2. Youssef RF, Lotan Y. Predictors of outcome of non-muscle-invasive and muscle-invasive bladder cancer. Sci World J 2011;11:369-81.
3. Malkowicz SB, Van Poppel H, Mickisch G, Pansadoro V, Thüroff J, Soloway MS, et al. Muscle-invasive urothelial carcinoma of the bladder. Urology 2007;69(1 Suppl.):3-16.
4. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 2001;19(3):666-75.
5. Takeuchi M, Sasaki S, Ito M, Okada S, Takahashi S, Kawai T, et al. Urinary bladder cancer: diffusion-weighted MR imaging - accuracy for diagnosing T stage and estimating histologic grade. Radiology 2009;251(1):112-21.
6. EI-Assmy A, Abou-EI-Ghar ME, Mosbah A, El-Nahas AR, Refaie HF, Hekal IA, et al. Bladder tumor staging: comparison of diffusion- and T2-weighted MR imaging. Eur Radiol 2009;19(7):1575-81.
7. Thoeny HC, Forstner R, De Keyzer F. Genitourinary applications of diffusion-weighted MR imaging in the pelvis. Radiology 2012;263(2):326-42.
8. Rosenkrantz AB, Mussi TG, Melamed J, Taneja SS, Huang WC. Bladder cancer: utility of MRI in detection of occult muscle-invasive disease. Acta Radiol 2012;53(6):695-9.
9. Wang HJ, Pui MH, Guo Y, Yang D, Pan BT, Zhou XH. Diffusion-weighted MRI in bladder carcinoma: the differentiation between tumor recurrence and benign changes after resection. Abdom Imaging 2013;39(1):135-41.
10. Avcu S, Koseoglu MN, Ceylan K, Bulut MD, Unal O. The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesion. Br J Radiol 2011;84(1006):875-82.
11. Kobayashi S, Koga F, Kajino K, Yoshita S, Ishii C, Tanaka H, et al. Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer. J Magn Reson Imaging 2014;39(1):172-8.
12. Rajesh A, Sokhi HK, Fung R, Mulcahy KA, Bankart MJ. Bladder cancer: evaluation of staging accuracy using dynamic MRI. Clin Radiol 2011;66(12):1140-5.
13. Daneshmand S, Ahmadi H, Huynh LN, Dobos N. Preoperative staging of invasive bladder cancer with dynamic gadolinium-enhanced magnetic resonance imaging: results from a prospective study. Urology 2012;80(6):1313-8.
14. Montironi R, Lopez-Beltran A. The 2004 WHO classification of bladder tumors: a summary and commentary. Int J Surg Pathol 2005;13(2):143-53.
15. Sobin LH, Gospodariwicz M, Wittekind C, editors. UICC international Union Against Cancer. TNM classification of malignant tumors. 7th edition New York: Wiley-Blackwell; 2011. p. 262-5.
16. Kobayashi S, Koga F, Yoshida S, Masuda H, Ishii C, Tanaka H, et al. Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol 2011;21(10):2178-86.
17. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007;188(6):1622-35.
18. Matsuki M, Inada Y, Tatsugami F, Tanikake M, Narabayashi I, Katsuoka Y. Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results. Eur Radiol 2007;17(1):201-4.
19. Abou-El-Ghar ME, El-Assmy A, Refaie HF, El-Diasty T. Bladder cancer: diagnosis with diffusion-weighted MR imaging in patients with gross hematuria. Radiology 2009;251(2):415-21.
20. Rosenkrantz AB, Mussi TC, Spieler B, Melamed J, Taneja SS, Huang WC. High-grade bladder cancer: association of the apparent diffusion coefficient with metastatic disease: preliminary results. J Magn Reson Imaging 2012;35(6):1478-83.
21. Tuncbilek N, Kaplan M, Altaner S, Atakan IH, Süt N, Inci O, et al. Value of dynamic contrast-enhanced MRI and correlation with tumor angiogenesis in bladder cancer. AJR Am J Roentgenol 2009;192(4):949-55.
22. Tannaphai P, Trimboli RM, Carbonaro LA, Viganò S, Di Leo G, Sardanelli F. Washout of mass-like benign breast lesions at dynamic magnetic resonance imaging. J Comput Assist Tomogr 2012;36(3):301-5.